| Ytd | -85.79% | |
| 1y | -96.10% |
| Open | 0.08 | Prev Close | 0.08 | Low | 0.08 | High | 0.10 | Mkt Cap | 126.14M |
| Vol | 16.06M | Avg Vol | 683.73K | EPS | -4.19 | P/E | N/A | Forward P/E | -1.50 |
| Beta | 3.37 | Short Ratio | 5.29 | Inst. Own | 13.93% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 3.03 | 200-d Avg | 3.24 | 1yr Est | 6.67 |
GSK to acquire Nuvalent for $10.6 billion, shares rise 38.2%. Other gainers include CCTG, CHAI, RGNT
href=https://www.benzinga.com/quote/RMSG target=_blank>(NASDAQ: RMSG) lost 67.6% to $0.69 in
Receives commitments for $65 million in new money financing to support ongoing business operationsRe